| lower blood pressure | 0.60 |
| develop jaundice | 0.47 |
| dilate blood vessels | 0.44 |
| increase blood flow | 0.42 |
| prevent the conversion … | 0.42 |
| cause birth defects | 0.40 |
| reduce aldosterone leve… | 0.37 |
| inhibit the activity of… | 0.32 |
| reduce the risk of kidn… | 0.32 |
| antagonize raas-induced… | 0.29 |
| More » |
| injury | 0.65 |
| death | 0.48 |
| higher rate of angioede… | 0.42 |
| death of the developing… | 0.33 |
| hyperkalemia | 0.30 |
| kidney failure | 0.28 |
| retention of potassium | 0.20 |
| effect | 0.68 |
| greater affinity | 0.32 |
| safe | 0.37 |
| less effective | 0.34 |
| cost-effective | 0.25 |
| preferred drugs | 0.26 |
| used in pregnancy | 0.71 |
| prescribed | 0.67 |
| used to treat heart fai… | 0.61 |
| used to treat high bloo… | 0.58 |
| used in combination | 0.48 |
| used to treat hypertens… | 0.48 |
| recommended as first-li… | 0.43 |
| discontinued | 0.41 |
| shown to cause agranulo… | 0.36 |
| associated with acute r… | 0.34 |
| More » |